Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
05 01 2019
Historique:
received: 11 12 2018
revised: 04 01 2019
accepted: 04 01 2019
entrez: 10 1 2019
pubmed: 10 1 2019
medline: 18 12 2019
Statut: epublish

Résumé

Immunotoxins are protein drugs composed of a targeting domain genetically fused to a protein toxin. One killing domain being explored is a truncated

Identifiants

pubmed: 30621280
pii: toxins11010020
doi: 10.3390/toxins11010020
pmc: PMC6356957
pii:
doi:

Substances chimiques

CTLA-4 Antigen 0
Exotoxins 0
GPI-Linked Proteins 0
Immunotoxins 0
Protein Synthesis Inhibitors 0
Mesothelin J27WDC343N

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : Z01 BC008753
Pays : United States

Références

Drug Des Devel Ther. 2009 Feb 06;2:105-14
pubmed: 19920898
Am J Pathol. 2018 Aug;188(8):1736-1743
pubmed: 29870741
Oncologist. 2015 Feb;20(2):176-85
pubmed: 25561510
Cancer Immunol Res. 2017 Aug;5(8):685-694
pubmed: 28674083
Cancer Discov. 2018 Nov;8(11):OF1
pubmed: 30262591
Radiographics. 2005 Sep-Oct;25(5):1357-68
pubmed: 16160116
Int Immunopharmacol. 2007 Sep;7(9):1185-91
pubmed: 17630197
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
Clin Cancer Res. 2016 Mar 1;22(5):1055-8
pubmed: 26463707
J Clin Oncol. 2015 Nov 1;33(31):3541-3
pubmed: 26261262
Nat Immunol. 2017 Feb 15;18(3):255-262
pubmed: 28198830
Cancer Immunol Immunother. 2008 Jan;57(1):115-21
pubmed: 17634939
N Engl J Med. 2016 Nov 10;375(19):1856-1867
pubmed: 27718784
Sci Transl Med. 2013 Oct 23;5(208):208ra147
pubmed: 24154601
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
Immunity. 2016 May 17;44(5):1069-78
pubmed: 27192570
Proc Natl Acad Sci U S A. 1975 Jun;72(6):2284-8
pubmed: 166383
Toxins (Basel). 2018 Nov 14;10(11):
pubmed: 30441807
Expert Opin Drug Deliv. 2013 Jul;10(7):907-26
pubmed: 23751126
Br J Cancer. 2015 Dec 1;113(11):1548-55
pubmed: 26554649
Clin Cancer Res. 2013 Jan 15;19(2):462-8
pubmed: 23169436
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Int J Cancer. 2004 Nov 10;112(3):475-83
pubmed: 15382075
J Neurooncol. 2004 Jan;66(1-2):197-201
pubmed: 15015787
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Leukemia. 2018 Aug;32(8):1768-1777
pubmed: 30030507
Breast Cancer Res Treat. 2003 Dec;82(3):155-64
pubmed: 14703062
Immunol Rev. 2016 Mar;270(1):152-64
pubmed: 26864110
Clin Cancer Res. 2006 Aug 1;12(15):4678-86
pubmed: 16899618
Neuro Oncol. 2005 Jan;7(1):90-6
pubmed: 15701286
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6902-6
pubmed: 8692916
J Clin Oncol. 2010 Aug 20;28(24):3838-43
pubmed: 20644085
PLoS Pathog. 2011 Feb;7(2):e1001289
pubmed: 21390206
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Cell. 2015 Apr 9;161(2):205-14
pubmed: 25860605
Nat Rev Microbiol. 2010 Feb;8(2):105-16
pubmed: 20023663
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E733-E742
pubmed: 29311317
Int Rev Immunol. 2017 Jul 4;36(4):207-219
pubmed: 28282218
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
J Neurooncol. 2003 Aug-Sep;64(1-2):125-37
pubmed: 12952293
N Engl J Med. 2016 Jun 30;374(26):2542-52
pubmed: 27093365
Cell Host Microbe. 2012 Apr 19;11(4):364-74
pubmed: 22520464
Annu Rev Med. 2007;58:221-37
pubmed: 17059365
Nat Rev Cancer. 2006 Jul;6(7):559-65
pubmed: 16794638
J Neurooncol. 2003 Oct;65(1):27-35
pubmed: 14649883
N Engl J Med. 2017 Mar 16;376(11):1015-1026
pubmed: 28212060
Infect Immun. 2012 Oct;80(10):3570-5
pubmed: 22851749
J Nucl Med. 2017 Sep;58(9):1421-1428
pubmed: 28360208
Neuro Oncol. 2008 Jun;10(3):320-9
pubmed: 18403491
Cell Host Microbe. 2012 Apr 19;11(4):375-86
pubmed: 22520465
Ann Oncol. 2012 Sep;23 Suppl 8:viii47-52
pubmed: 22918928
J Nucl Med. 2010 Mar;51(3):340-6
pubmed: 20150263
Cell Immunol. 2018 Dec;334:38-41
pubmed: 30213644
Infect Immun. 1991 Jan;59(1):240-6
pubmed: 1987039
N Engl J Med. 2013 Jul 11;369(2):134-44
pubmed: 23724846
Cell. 2010 Mar 19;140(6):771-6
pubmed: 20303867

Auteurs

Yasmin Leshem (Y)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA. jasminleshem@gmail.com.
Laboratory of Molecular Immunology, Faculty of Biology and Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3200003, Israel. jasminleshem@gmail.com.

Ira Pastan (I)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA. pastani@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH